Charles River Laboratories International, Inc. (CRL) vs ICON Public Limited Company (ICLR)

A side-by-side comparison of Charles River Laboratories International, Inc. and ICON Public Limited Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 3, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CRL vs ICLR

growth of $100 · dividends reinvested · last 10y
CRL +249.3% (+13.3%/yr)ICLR +112.9% (+7.8%/yr)CRL compounded faster over this window
100200300400500Start $10020182020202220242026$349$213
CRL ICLR

CRL vs ICLR: by the numbers

  • •CRL is the larger company ($13.98B vs $12.41B market cap).
  • •ICLR is profitable (3.99% net margin) while CRL runs a net loss (-5.96%).
  • •ICLR grew revenue faster over the past five years (20.93% vs 4.08% CAGR).

Metrics side by side

Valuation

MetricCRLICLR
P/E ratioN/A38.04
Forward P/E25.5715.30
P/S ratio3.501.50
P/B ratio4.921.32
EV / EBITDA21.2410.60
FCF yield2.65%10.85%

Profitability

MetricCRLICLR
Gross margin32.24%21.85%
Operating margin12.35%10.15%
Net margin-5.96%3.99%
ROE-8.40%3.51%
ROIC7.72%4.80%

Growth (annualized)

MetricCRLICLR
Revenue CAGR (5Y)4.08%20.93%
EPS CAGR (5Y)N/A-14.23%
FCF CAGR (5Y)6.43%22.10%
Total return CAGR (5Y)-6.98%-9.18%

Frequently asked

Which has grown faster, CRL or ICLR?
Over the past five years, ICLR grew revenue faster — CRL at a 4.08% CAGR versus ICLR at 20.93%.
Is CRL or ICLR more profitable?
ICLR runs the higher net margin — CRL at -5.96% versus ICLR at 3.99%.
How have CRL and ICLR total returns compared?
Over the past 10 years, CRL delivered 13.28% and ICLR delivered 7.67% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 3, 2026.